4-(2-Aminopropyl)benzofuran (4-APB) is a monoamine releasing agent and novel designer drug of the benzofuran family. It acts as a serotoninâÂÂnorepinephrineâÂÂdopamine releasing agent (SNDRA). The drug was first detected, in Europe, by 2011.